LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
$ 398,000
Miscellaneous Businesses for Sale
Post Office Businesses for Sale
Banquet Halls & Catering Businesses for Sale
Gift & Flower Shops for Sale
Finance & Accounting Businesses for Sale
Real Estate & Property Management Companies for Sale
Vending & Kiosk Businesses for Sale
Warehouse & Storage Businesses for Sale
Pet Businesses for Sale
Childcare & Educational Businesses for Sale
Vending & Kiosk Franchises for Sale
Entertainment & Recreation Franchise Opportunities
Clothing & Shoe Store Franchise Opportunities
Senior Care Franchise for Sale
Beauty & Personal Care Franchises for Sale
Child Care & Education Franchise Opportunities
Automotive Franchises for Sale
Manufacturing Franchises for Sale
Home Based Franchise Opportunities
Miscellaneous Franchises for Sale
Commercial Spaces for Sale or Lease
Medical Office Spaces for Sale or Rent
Land & Developments for Sale
Medical Buildings for Sale or Lease
Industrial Buildings for Sale or Lease
Office Spaces for Sale or Rent
Commercial Buildings for Sale or Lease
Places of Worship for Sale
Retail Buildings for Sale or Lease
Mixed Use Buildings for Sale or Rent
An email will be sent to registered email address.
Please select if you are: